VINORELBINE Injection, USP

LATEX-FREE • PRESERVATIVE-FREE • AP RATED

Brand Name Equivalent: NAVELBINE	Electronic Catalog
Therapeutic Category: Antineoplastic Agent

SAGENT delivers injectables excellence in oncology:
• Available in:
- 10 mg per 1 mL single-dose vials
- 50 mg per 5 mL single-dose vials
• Enhanced packaging and labeling designed to promote safety and help reduce medication errors,
including:
- Easy-to-read drug name and dosage strength
- Bar coding
• LATEX-FREE
• Preservative-free

NDC #25021	Description	Strength	Fill Volume	Concentration	Container Size	Closure	Unit of Sale	Package Insert	Storage Requirements	Product Photos	360^o View
204-01	Glass Vial	10 mg	1 mL	10 mg per mL	5 mL	20 mm	1
204-05	Glass Vial	50 mg	5 mL	10 mg per mL	8 mL	20 mm	1

MSDS Sheet Bar Codes Wholesaler Item Numbers

WARNING:
Vinorelbine Injection, USP should be administered under the supervision of a physician experienced in the use of cancer chemotherapeutic agents. This product is for intravenous (IV) use only. Intrathecal administration of other vinca alkaloids has resulted in death. Syringes containing this product should be labeled “WARNING - FOR IV USE ONLY. FATAL if given intrathecally.” Severe granulocytopenia resulting in increased susceptibility to infection may occur. Granulocyte counts should be ˜ 1,000 cells/mm3 prior to the administration of vinorelbine. The dosage should be adjusted according to complete blood counts with differentials obtained on the day of treatment. Caution - It is extremely important that the intravenous needle or catheter be properly positioned before vinorelbine is injected. Administration of vinorelbine may result in extravasation causing local tissue necrosis and/or thrombophlebitis (see DOSAGE AND ADMINISTRATION: Administration Precautions).

Please refer to full prescribing information.


[Back to Products page]	This product information is intended for U.S. residents only. All trademarks and registered trademarks are the property of their respective owners.